LAWRENCE, Mass., May 24, 2012 /PRNewswire/ -- NxStage ® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced the latest interim findings from its FREEDOM (Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements) Study, which found daily home hemodialysis treatments with the NxStage System One™ are associated with long-term improvements in various physical and mental quality of life measures. These interim FREEDOM Study results, "At-Home Short Daily Hemodialysis Improves the Long-Term Health-Related Quality of Life," were published online on Kidney International's website in advance of its release in print.

(Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO )

NxStage's FREEDOM Study is the largest prospective study of frequent home hemodialysis to date. The FREEDOM Study reported improvements in several quality of life measures in end stage renal disease (ESRD) patients at 12 months of follow-up, including:

• Sustained improvements in the physical-component summary (PCS) score and mental-component summary (MCS) score at four and 12 months;
• Significant improvements in all six PCS-specific domains (physical functioning, role physical, bodily pain, general health, vitality and social functioning) and one of two MCS-specific domains (mental health) over 12 months; and
• More than doubling the proportion of participants with a PCS score greater than or equal to 50, increasing from nine percent at baseline to 21 percent at 12 months in the as-treated cohort.

"Today's data shows more frequent home hemodialysis unlocks a variety of clinical and quality of life benefits for ESRD patients that remain over an extended period of time," said Frederic Finkelstein, MD, Chief of Nephrology at the Hospital of St. Raphael in New Haven, Conn. and Clinical Professor of Medicine at Yale University Medical School, as well as the study's primary author. "ESRD patients struggle on a daily basis with maintaining their overall health while trying to better manage their chronic condition. This data shows that more frequent home hemodialysis can have a positive impact on a patient's perception of his quality of life."

"This recent data builds upon an already robust mountain of clinical evidence pointing to the benefits of more frequent home hemodialysis," said Jeffrey H. Burbank, Chief Executive Officer of NxStage Medical, Inc. "FREEDOM continues to show that more frequent home therapy with the NxStage System One transforms patient lives for the better, resulting in healthier, happier patients who are empowered in their own healthcare."

About the NxStage System One

The NxStage System One is the first and only truly portable hemodialysis system cleared for home use by the U.S. Food & Drug Administration (FDA). Its simplicity and revolutionary size (just over a foot tall) are intended to allow convenient use in patients' homes and give patients the freedom to travel with their therapy.   When combined with the NxStage Pureflow™ SL Dialysis Preparation System, patients are able to further simplify, using ordinary tap water to create dialysis fluid on demand.  Unlike conventional hemodialysis systems, the System One requires no special infrastructure to operate. Under the guidance of their physician, patients can use the NxStage System One, with their trained partners, where, how and when it best meets their needs, at home or on vacation. http://www.nxstage.com/.

About NxStage Medical

NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative systems for the treatment of ESRD and acute kidney failure. For more information on NxStage and its products, please visit the company's website at http://www.nxstage.com/.

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including those that are discussed in NxStage's filings with the Securities and Exchange Commission, including the Quarterly Report on Form 10-Q for the quarter ended March 31, 2012. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

Kristen K. Sheppard, Esq. 
VP, Investor Relations 
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

SOURCE NxStage Medical, Inc.

RELATED LINKS
http://www.nxstage.com

...

WASHINGTON, May 24, 2012 /NEWS.GNOM.ES/ – Dialysis Patient Citizens (DPC) is proud to announce Eric Edwards has been named President of the DPC Board of Directors.  Edwards, a longtime advocate for kidney disease patients, has been a DPC Board Member since 2010.

“I am honored and excited to take on this new opportunity.  I have always felt my purpose on Earth has been to inform and empower ESRD patients and their families, because when you know better, you do better,” said Eric Edwards.  “I look forward to working with the Board of Directors and DPC’s patient membership to further our mission of improving the quality of life for all dialysis patients.”

Eric Edwards was diagnosed with Nephritis at an early age and began his journey as an ESRD patient at age nineteen.  He received his first kidney transplant in 1999 and returned to hemodialysis six years later when the transplant failed.  Eric joined the Board of Directors in 2010 and previously served as a DPC Patient Ambassador for several years.  He holds a dual B.B.A. in Finance and Marketing from J. Mack Robinson College of Business at Georgia State University and lives in Atlanta, GA.

Eric Edwards succeeds former President Nancy Scott, who served as President from April 2011.  Her term ended prematurely after she received a kidney transplant last spring, as the DPC by-laws require the Board President be a current dialysis patient.  Scott will continue to serve on the Board of Directors and as the Chair of the Education Committee.

“Nancy Scott has been a relentless advocate for her fellow kidney patients around the country and her contributions to our organization during her short tenure as President have been innumerable,”said Hrant Jamgochian, DPC Executive Director.  “While she will no longer serve as Board President, we are excited about her dedication to our mission and her continued involvement with our organization.”

About Dialysis Patient Citizens: Dialysis Patient Citizens is a nationwide, non-profit, patient-led organization working to improve the quality of life for all dialysis patients through education and advocacy. The Board of Directors is comprised solely of end stage renal disease (ESRD) patients who guide the policies and mission of the organization. You can find more information atwww.dialysispatients.orgrel='nofollow'>.

Press Contact:
Jessica Nagro
202-789-6931

SOURCE Dialysis Patient Citizens

www.dialysispatients.org

...

VERNON HILLS, Ill.— Lifeline Vascular Access, announced the opening of a new vascular center serving nephrology practices and dialysis patients across the Tampa Bay area.

Richard Nee, vice president and general manager for Lifeline, said Lifeline Vascular Center Tampa is the company's fourth facility of its kind in the state of Florida and 66^th nationally and is pleased to be able to help improve the quality of care available to Tampa-area dialysis patients.

"There are more than 20,000 patients on hemodialysis in the state and nearly all of them will, at some point, require intervention for an access issue. Research shows that the availability of outpatient vascular access services enhances the continuity of their care and significantly improves their clinical outcomes."

Nee says the Tampa area has more than 30 dialysis centers in the area, and there is a significant patient population who will benefit from the convenience of this new freestanding outpatient location.

Gerald Beathard, MD, PhD, vice president of Provider Development, agreed. "The Lifeline Vascular Access system of centers represents more than half a million successful patient encounters. Our physicians and staff have posted a procedure success rate of 98 percent and a patient satisfaction rate of 93 percent. These numbers are well above national benchmarks and we're committed to the task of improving the quality of life for the patients we serve."

Lifeline Vascular Access, which now operates 66 centers in the U.S. and Puerto Rico, was recently re-accredited by The Joint Commission. Awarded its first accreditation in 2006, the company received the nationally recognized Joint Commission Gold Seal of Approval, which reflects a commitment to quality healthcare performance standards and patient safety.

...

WASHINGTON, May 24, 2012 /PRNewswire-USNewswire/ -- Dialysis Patient Citizens (DPC) is proud to announce Eric Edwards has been named President of the DPC Board of Directors.  Edwards, a longtime advocate for kidney disease patients, has been a DPC Board Member since 2010.

"I am honored and excited to take on this new opportunity.  I have always felt my purpose on Earth has been to inform and empower ESRD patients and their families, because when you know better, you do better," said Eric Edwards.  "I look forward to working with the Board of Directors and DPC's patient membership to further our mission of improving the quality of life for all dialysis patients."

Eric Edwards was diagnosed with Nephritis at an early age and began his journey as an ESRD patient at age nineteen.  He received his first kidney transplant in 1999 and returned to hemodialysis six years later when the transplant failed.  Eric joined the Board of Directors in 2010 and previously served as a DPC Patient Ambassador for several years.  He holds a dual B.B.A. in Finance and Marketing from J. Mack Robinson College of Business at Georgia State University and lives in Atlanta, GA.

Eric Edwards succeeds former President Nancy Scott, who served as President from April 2011.  Her term ended prematurely after she received a kidney transplant last spring, as the DPC by-laws require the Board President be a current dialysis patient.  Scott will continue to serve on the Board of Directors and as the Chair of the Education Committee.

"Nancy Scott has been a relentless advocate for her fellow kidney patients around the country and her contributions to our organization during her short tenure as President have been innumerable,"said Hrant Jamgochian, DPC Executive Director.  "While she will no longer serve as Board President, we are excited about her dedication to our mission and her continued involvement with our organization."

About Dialysis Patient Citizens: Dialysis Patient Citizens is a nationwide, non-profit, patient-led organization working to improve the quality of life for all dialysis patients through education and advocacy. The Board of Directors is comprised solely of end stage renal disease (ESRD) patients who guide the policies and mission of the organization. You can find more information atwww.dialysispatients.org.

Press Contact:
Jessica Nagro
202-789-6931

SOURCE Dialysis Patient Citizens

...